lobbying_activities: 3243967

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3243967	2f967441-211b-400d-91af-14e4a0fd4cd8	Q3	FORBES-TATE	400976792	INDEPENDENT PHARMACY COOPERATIVE	2024	third_quarter	PHA	Issues related to pharmacy regulation, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency and reform; Issues related to S.127 - Pharmacy Benefit Manager Transparency Act of 2023; Issues related to S.1339 - Pharmacy Benefit Manager Reform Act; Issues related to H.R.3561 - PATIENT Act of 2023; Issues related to S.2973 - Modernizing and Ensuring PBM Accountability Act; Issues related to H.R.5378 - the Lower Costs, More Transparency Act.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2024-10-17T14:20:50-04:00